Prot #EFC13579: A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients with Persistent Asthma

Project: Research project

Project Details

StatusFinished
Effective start/end date11/3/15 → 11/3/18

Funding

  • Sanofi US Services Inc. (Prot #EFC13579)